STOCK TITAN

Coeptis Therapeutics Inc SEC Filings

COEP NASDAQ

Welcome to our dedicated page for Coeptis Therapeutics SEC filings (Ticker: COEP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Coeptis Therapeutics Holdings Inc. filings document the issuer’s completed merger-related corporate transition, including the name change to Z Squared Inc. and the surviving operating subsidiary Z Squared OpCo Inc. The record includes Form 8-K material-event reports covering capital-structure changes, governance matters, shareholder voting matters, material agreements, operating and financial results, and clinical or regulatory disclosures connected to Coeptis's biotechnology operations.

Additional filings document security-status and compensation matters, including a Form 25 for removal of warrants from Nasdaq listing and registration and an option repricing and exchange program under the 2022 Equity Incentive Plan. The disclosures also cover capital-structure instruments associated with material agreements.

Rhea-AI Summary

Z Squared Inc. granted Co-Chief Executive Officer David Elias Halabu a stock option award covering 500,000 shares of common stock. The option has an exercise price of $15.20 per share and was issued as compensation under his amended and restated executive employment agreement and the company’s 2025 Incentive Compensation Plan.

The option vests in full only if the fair market value of Z Squared’s common stock rises by 50% above the grant-date fair market value, as determined by the board. Once vested, the option is exercisable for up to 10 years from the grant date, subject to earlier termination under the plan and applicable award agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Fuerst Bryan Eric reported acquisition or exercise transactions in this Form 4 filing.

Z Squared Inc. director Bryan Eric Fuerst received a grant of 9,868 restricted stock units on April 27, 2026 as part of his independent director compensation. This is a stock-based award, not a market purchase or sale.

The RSUs have a grant-date fair value of $150,000 and were issued under the company’s 2025 Incentive Compensation Plan and Non-Employee Director Compensation Program. Each RSU represents one share of common stock upon vesting. The award vests in 36 equal monthly installments starting April 27, 2026, contingent on Mr. Fuerst’s continued Board service. Following this grant, he holds 9,868 RSUs directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cooper Kenneth Lyle reported acquisition or exercise transactions in this Form 4 filing.

Z Squared Inc. director Kenneth Lyle Cooper reported an award of 9,868 restricted stock units on April 27, 2026. The RSUs have a grant-date fair value of $150,000 and were issued under the company’s 2025 Incentive Compensation Plan and Non-Employee Director Compensation Program.

Each RSU represents one share of common stock and was granted at no cash cost to Cooper as part of his independent director compensation. The award vests in 36 equal monthly installments beginning April 27, 2026, contingent on his continued Board service, and his reported RSU holdings after the grant total 9,868 units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Z Squared Inc. granted its Chief Financial Officer, Brian Cogley, new equity awards as part of an amended and restated executive employment agreement. On April 27, 2026, he received 100,000 stock options with an exercise price of $15.20 per share. These options vest in full once the Board determines the fair market value of the common stock has increased by 50% above the grant-date fair market value and remain exercisable for ten years, subject to plan terms.

He also received 16,447 restricted stock units (RSUs), representing a grant value of $250,000 based on the Nasdaq closing price on April 27, 2026. The RSUs vest in equal quarterly installments over one year, contingent on his continued employment. Both awards are issued under the Z Squared Inc. 2025 Incentive Compensation Plan and function as compensation grants rather than open-market purchases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Burke Michelle Ellen reported acquisition or exercise transactions in this Form 4 filing.

Z Squared Inc. reported that Co-Chief Executive Officer Michelle Ellen Burke received a grant of 16,447 shares of common stock on April 27, 2026. This award was issued at no cash cost to her as part of her compensation.

The grant represents the first of four equal quarterly stock tranches under an Amendment to her Service Agreement, which provides for $1,000,000 worth of Z Squared common stock in total. The 16,447 shares were calculated by dividing $250,000 by the closing price of Z Squared’s common stock on the Nasdaq Global Market on April 27, 2026, rounded down to the nearest whole share. Following this transaction, she directly holds 16,447 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Z Squared Inc. director Sohn Adam Craig filed an initial Form 3, which is a statement of beneficial ownership for company insiders. The filing does not list any buy, sell, or other equity transactions and shows no reported derivative positions in this snapshot.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Z Squared Inc. filed an initial insider ownership report for Chief Marketing Officer Christopher Ryan Schadel. The Form 3 data shows no reported transactions in the company’s securities, and no derivative positions or holdings are listed in the summary provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Z Squared Inc. director and Co-Chief Executive Officer Halabu David Elias filed an initial ownership report showing an indirect stake in the company’s common stock through SMSC Capital Holdings LLC. SMSC holds 1,412,855 shares of Z Squared common stock, received at the closing of a merger under an Agreement and Plan of Merger.

The filing explains that Halabu owns a 1% membership interest in SMSC, while the David E. Halabu Irrevocable Trust, for which he serves as trustee, owns the remaining 99%. Halabu expressly disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Z Squared Inc. filed an initial Form 3 identifying Bryan Eric Fuerst as a director of the company. This form serves as his initial statement as a reporting person for the issuer's equity securities. The filing does not list any transactions or current holdings in either non-derivative or derivative securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Z Squared Inc. director Kenneth Lyle Cooper has filed an initial Form 3, which is a statement of beneficial ownership for insiders. The available data show no reported transactions, share holdings, or derivative positions in this filing, indicating it is a baseline disclosure of status as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Coeptis Therapeutics (COEP) SEC filings are available on StockTitan?

StockTitan tracks 53 SEC filings for Coeptis Therapeutics (COEP), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Coeptis Therapeutics (COEP)?

The most recent SEC filing for Coeptis Therapeutics (COEP) was filed on April 30, 2026.